共 50 条
- [1] Safety, tolerability, and efficacy of PBT2 in Huntington's disease: a phase 2, randomised, double-blind, placebo-controlled trialLANCET NEUROLOGY, 2015, 14 (01): : 39 - 47Angus, D.Herd, C.Stone, C.Stout, J.Wieler, M.Reilmann, R.Ritchie, C. W.Dorsey, E. R.Helles, K.Kayson, E.Oakes, D.Rosas, H. D.Vaughan, C.Panegyres, P. K.Ames, D.Goh, A.Agarwal, P.Churchyard, A.Murathodizic, M.Chua, P.Germaine, D.Lim, L.Mack, H.Loy, C.Griffith, J.Mitchell, P.Corey-Bloom, J.Gluhm, S.Goldstein, J.Levi, L.Margolis, R.Yoritomo, N.Janicki, S.Marder, K.Clouse, R.Singer, C.Moore, H.Padron, N.Kostyk, S.Daley, A.Segro, V.Kumar, R.Anderson, K.Drazinic, C.Hennig, B.Nance, M.Molho, E.Criswell, S.LeDoux, M. S.Guyot, S.
- [2] Etanercept in Alzheimer disease: A randomized, placebo-controlled, double-blind, phase 2 trialNEUROLOGY, 2015, 84 (21) : 2161 - 2168Butchart, JosephBrook, LauraHopkins, VivienneTeeling, JessicaPuentener, UrsulaCulliford, DavidSharples, RichardSharif, SaifMcFarlane, BradyRaybould, RachelThomas, RhodriPassmore, PeterPerry, V. HughHolmes, Clive
- [3] ETANERCEPT IN ALZHEIMER DISEASE: A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, PHASE 2 TRIALNEUROLOGY, 2015, 85 (23) : 2083 - 2084Tufan, Ayse N.Tufan, Fatih
- [4] A Randomized, Double-Blind, Placebo-Controlled Trial of Pridopidine in Huntington's DiseaseMOVEMENT DISORDERS, 2013, 28 (10) : 1407 - 1415Kieburtz, KarlMcGarry, AndrewMcDermott, MichaelKayson, EliseHarrison, MadalineMarder, KarenWalker, Francis
- [5] A Randomized, Double-Blind, Placebo-Controlled Trial Evaluating Cysteamine in Huntington's DiseaseMOVEMENT DISORDERS, 2017, 32 (06) : 932 - 936Verny, ChristopheBachoud-Levi, Anne-CatherineDurr, AlexandraGoizet, CyrilAzulay, Jean-PhilippeSimonin, ClemenceTranchant, ChristineCalvas, FabienneKrystkowiak, PierreCharles, PerrineYoussov, KatiaScherer, ClarissePrundean, AdrianaOlivier, AudreyReynier, PascalSaudou, FredericMaison, PatrickAllain, Philippevon Studnitz, EricaBonneau, Dominique
- [6] Ethyl-EPA in Huntington disease - A double-blind, randomized, placebo-controlled trialNEUROLOGY, 2005, 65 (02) : 286 - 292Puri, BKLeavitt, BRHayden, MRRoss, CARosenblatt, AGreenamyre, JTHersch, SVaddadi, KSSword, AHorrobin, DFManku, MMurck, H
- [7] Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease:: a phase IIa, double-blind, randomised, placebo-controlled trialLANCET NEUROLOGY, 2008, 7 (09): : 779 - 786Lannfelt, LarsBlennow, KajZetterberg, HenrikBatsman, StellanAmes, DavidHrrison, JohnMasters, Colin L.Targum, SteveBush, Ashley I.Murdoch, RossWilson, JanetRitchie, Craig W.
- [9] Doxycycline in Creutzfeldt-Jakob disease: A phase 2, randomized, double-blind, placebo-controlled trialPRION, 2013, 7 : 62 - 62Brandel, Jean-PhilippeMarcon, GabriellaCoudert, MathieuTettamanti, MauroWelaratne, ArletteGiacone, GeorgioAzimi, ShohrehPietrini, VladimiroFabreguettes, Jean-RochImperiale, DanieleAucan, ChristopheLucca, UgoMallet, AlainSalmona, MarioZerr, IngaRedaelli, VeronicaForloni, GianluigiHaik, StephaneTagliavini, Fabrizio
- [10] A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington diseaseNEUROLOGY, 2017, 88 (02) : 152 - 159McGarry, AndrewMcDermott, MichaelKieburtz, Karlde Blieck, Elisabeth A.Beal, FlintMarder, KarenRoss, ChristopherShoulson, IraGilbert, PeterMallonee, William M.Guttman, MarkWojcieszek, JoanneKumar, RajeevLeDoux, Mark S.Jenkins, MaryRosas, H. DianaNance, MarthaBiglan, KevinComo, PeterDubinsky, Richard M.Shannon, Kathleen M.O'Suilleabhain, PadraigChou, KelvinWalker, FrancisMartin, WayneWheelock, Vicki L.McCusker, ElizabethJankovic, JosephSinger, CarlosSanchez-Ramos, JuanScott, BurtonSuchowersky, OksanaFactor, Stewart A.Higgins, Donald S., Jr.Molho, EricRevilla, FredyCaviness, John N.Friedman, Joseph H.Perlmutter, Joel S.Feigin, AndrewAnderson, KarenRodriguez, RamonMcFarland, Nikolaus R.Margolis, Russell L.Farbman, Eric S.Raymond, Lynn A.Suski, ValerieKostyk, SandraColcher, AmySeeberger, Lauren
